Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 61 of 82 found articles
 
 
  Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer
 
 
Title: Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer
Author: J. A. OShaughnessy
J. Blum
V. Moiseyenko
S. E. Jones
D. Miles
D. Bell
R. Rosso
L. Mauriac
B. Osterwalder
H.-U. Burger
S. Laws
Appeared in: Annals of oncology
Paging: Volume 12 (2001) nr. 9 pages 8 p.
Year: 2001-09
Contents:
Publisher: Kluwer Academic Publishers, Dordrecht, The Netherlands
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 61 of 82 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands